IL1B and tuberculosis: Another study involving 130 TB patients from Brazil, Uganda and South Africa reported that combining BMI, culture time to positivity, and biomarkers (e.g. IL1β, CXCL10, IL-22, and complement C3) demonstrated over 80% sensitivity for relapse prediction, a dramatic improvement over culture alone (Mutavhatsindi et al., 2024).